Clinical trial
Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple…
NCT00342134 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00342134 |
|---|---|
| Title | Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis |
| Official title | Immunological Mechanisms of Immune Ablation and Autologous Hematopoietic Stem Cell Transplantation in Secondary Progressive Multiple Sclerosis |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Procedure |
| Interventions | Stem Cell Transplanataion |
| Enrollment | 34 |
| Start date | May 1, 2002 |
| Primary completion | May 4, 2011 |
| Completion | May 4, 2011 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: